GRN-related frontotemporal lobar degeneration
Last updated 13 Nov 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
GRN-related frontotemporal lobar degeneration is a progressive brain disorder that can affect behaviour, language, and movement. The symptoms of this disorder usually become noticeable in a person's fifties or sixties, and affected people typically survive 7 to 13 years after the appearance of symptoms. However, symptoms can begin as early as a person's thirties or as late as a person's eighties. The features of this condition vary significantly, even among affected members of the same family.
Video picks for Genetic conditionsVideo library
Description
GRN-related frontotemporal lobar degeneration is a progressive brain disorder that can affect behaviour, language, and movement. The symptoms of this disorder usually become noticeable in a person's fifties or sixties, and affected people typically survive 7 to 13 years after the appearance of symptoms. However, symptoms can begin as early as a person's thirties or as late as a person's eighties. The features of this condition vary significantly, even among affected members of the same family.
Behavioural changes are the most common early signs of GRN-related frontotemporal lobar degeneration. These include marked changes in personality, judgement, and insight. It may become difficult for affected individuals to interact with others in a socially appropriate manner. Affected people may also become easily distracted and unable to complete tasks. They increasingly require help with personal care and other activities of daily living.
Many people with GRN-related frontotemporal lobar degeneration develop progressive problems with speech and language (aphasia). Affected individuals may have trouble speaking, remembering words and names (dysnomia), and understanding speech. Over time, they may completely lose the ability to communicate (mutism). People with this condition also experience a decline in intellectual function (dementia).
Some people with GRN-related frontotemporal lobar degeneration also develop movement disorders, such as parkinsonism and corticobasal syndrome. The signs and symptoms of these disorders include tremors, muscle stiffness (rigidity), unusually slow movement (bradykinesia), walking problems (gait disturbance), involuntary muscle spasms (myoclonus), uncontrolled muscle tensing (dystonia), and an inability to carry out purposeful movements (apraxia).
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Frontotemporal lobar degeneration
FTD-GRN
FTD-PGRN
FTDP-17 GRN
FTDU-17
FTLD
FTLD with TDP-43 pathology
FTLD-TDP
GRN-related frontotemporal dementia
HDDD1
HDDD2
Hereditary dysphasic disinhibition dementia
Patient picks for Genetic conditions

Eye health
Macular degeneration
Age-related macular degeneration is the most common cause of sight impairment in those aged over 50. It causes a gradual loss of central vision, which is needed for detailed work and for things like reading and driving. Edge vision (peripheral vision) is not lost.
by Dr Colin Tidy, MRCGP

General health
Asbestos-related diseases
People exposed to asbestos can develop diseases in later life. These most commonly affect the lungs but can also affect the lining of the tummy (abdomen). Some conditions - for example, mesothelioma or lung cancer - are more serious than others. This leaflet gives a brief overview of the diseases that are related to having an exposure to asbestos in the past.
by Dr Louise Newson, MRCGP

Chest and lungs
SARS and MERS virus
Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) are viral infections. Both infections can cause very serious illnesses that particularly affect the lungs. SARS caused many infections, especially in Asia, in 2002-2004 but was not heard of for some time. A SARS-CoV-2 (COVID-19) outbreak emerged in Wuhan, China in December 2019. This spread rapidly and was declared a global pandemic in 2020. MERS was first recognised in the Middle East in 2012. Most of the initial infections were in the Middle East. However, by February 2018, the World Health Organization (WHO) had reported cases in many other countries.
by Dr Hayley Willacy, FRCGP

Travel and vaccinations
Zika virus
Zika virus was a rare illness before 2015 when a sudden outbreak in Brazil became the subject of international headlines. However, it has been at a relatively low level since 2018. You can catch Zika virus if you are bitten by an affected mosquito. Zika virus is usually a very mild illness. However, it is possibly the cause of birth defects in babies born to mothers who have the infection in pregnancy. It may also cause other complications. Concern about the possible link of these conditions with Zika virus led the World Health Organization (WHO) to declare it a public health emergency of international concern. Research on the prevention of Zika virus is ongoing.
by Dr Hayley Willacy, FRCGP

Eye health
Presbyopia
Age-related long-sight (presbyopia) is a normal part of ageing and is not a disease. As you get older, you find it more difficult to see (focus on) near objects. The problem can be corrected by wearing reading glasses or contact lenses. Presbyopia is a type of sight problem called a refractive error.
by Dr Colin Tidy, MRCGP

Travel and vaccinations
Ears and flying
Aeroplane ear, or the feeling of blocked or painful ears while flying, is caused by pressure changes. Usually your ears will settle soon after landing. Occasionally pain or a feeling of blockage drags on; if it does, see your doctor.
by Dr Doug McKechnie, MRCGP
Related patient information and medicines

Patient information leaflet
Memory loss and dementia
Lewy body dementia This is a type of dementia caus... It can cause hallucinations, movement problems, and unpredictable changes in thinking and alertness that can fluctuate from day-to-day. Frontotemporal dementia This is a type of dementia that causes the frontal and temporal lobes of the brain to shrink and stop working. It often causes problems.

Patient information leaflet
Temporal lobe lesions
The temporal lobe of the brain is involved in understanding and remembering what we see (vision), understanding speech and language, and understanding emotions. The temporal lobe can be affected by various conditions, particularly a stroke, brain tumour or head or brain injury. Progressive worsening of language can be part of a type of dementia.

Patient information leaflet
Causes of memory loss and dementia
So, doing things such as... Who gets dementia. It is estimated that in 2019, there were almost 885,000 people aged 65 years and over living with dementia in the UK. By 2040 this number is expected to increase to almost 1.6 million. For example, stiffness, slowness of movement and a shuffling walk with difficulty in starting, stopping, and in.

Patient information leaflet
Visual problems
What is visual loss. Visual loss can be partial (meaning the vision is impaired or hazy or that the visual field is reduced) or complete (meaning all or part of the vision in one or both eyes is too poor for useful function). It may occur with or without pain, suddenly or gradually. Visual problems can arise from problems affecting different parts.

Patient information leaflet
Charles Bonnet syndrome
Charles Bonnet syndrome is a common condition experienced by people who are losing, or have lost, their sight. It involves seeing things which are not really there (having visual hallucinations). It can occur in anyone who has experien... This includes people experiencing conditions such as age-related macular degeneration Macular degeneration ,.

Patient information leaflet
Spinal disc problems
Spinal discs are also called intervertebral discs. There is a spinal disc between each bone (vertebra) in your spine. This keeps the vertebrae separated and acts as a shock absorber. As we get older the spinal discs gradually become damaged and this can cause problems such as back pain. Other problems affecting the spinal discs include a slipped.
Further reading and references
- GRN-related frontotemporal lobar degeneration; MedlinePlus, National Library of Medicine.
- Chen Q, Boeve BF, Senjem M, Tosakulwong N, Lesnick T, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Graff-Radford J, Graff-Radford N, Jack CR Jr, Jones D, Knopman D, Kremers WK, Lapid M, Rademakers R, Ramos EM, Syrjanen J, Boxer AL, Rosen H, Wszolek ZK, Kantarci K. Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study. Neurobiol Aging. 2020 Apr;88:42-50. doi: 10.1016/j.neurobiolaging.2019.12.004. Epub 2019 Dec 12.
- Hsiung GYR, Feldman HH. GRN Frontotemporal Dementia. 2007 Sep 7 [updated 2020 Feb 6]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1371/
- Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, Hahn-Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, Mikol J, Deramecourt V, Lejeune P, de la Sayette V, Belliard S, Vercelletto M, Meyrignac C, Van Broeckhoven C, Lambert JC, Verpillat P, Campion D, Habert MO, Dubois B, Brice A; French research network on FTD/FTD-MND. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008 Mar;131(Pt 3):732-46. doi: 10.1093/brain/awn012. Epub 2008 Feb 1.
- Rabins PV, Rovner BW, Rummans T, Schneider LS, Tariot PN. Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Focus (Am Psychiatr Publ). 2017 Jan;15(1):110-128. doi: 10.1176/appi.focus.15106. Epub 2017 Jan 11.
- Ramos EM, Dokuru DR, Van Berlo V, Wojta K, Wang Q, Huang AY, Deverasetty S, Qin Y, van Blitterswijk M, Jackson J, Appleby B, Bordelon Y, Brannelly P, Brushaber DE, Dickerson B, Dickinson S, Domoto-Reilly K, Faber K, Fields J, Fong J, Foroud T, Forsberg LK, Gavrilova R, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Heuer HW, Hsiung GR, Huey E, Irwin D, Kantarci K, Karydas A, Kaufer D, Kerwin D, Knopman D, Kornak J, Kramer JH, Kremers W, Kukull W, Litvan I, Ljubenkov P, Lungu C, Mackenzie I, Mendez MF, Miller BL, Onyike C, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Shaw L, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wong B, Wszolek Z, Rademakers R, Boeve BF, Rosen HJ, Boxer AL; ARTFL/LEFFTDS consortium; Coppola G. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020 Jan;16(1):118-130. doi: 10.1002/alz.12011.
- Staffaroni AM, Bajorek L, Casaletto KB, Cobigo Y, Goh SM, Wolf A, Heuer HW, Elahi FM, Ljubenkov PA, Dever R, Kornak J, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dheel C, Dickerson BC, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fields JA, Fishman A, Fong J, Foroud T, Forsberg LK, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung GY, Huey ED, Irwin DJ, Jones DT, Jones L, Kantarci K, Karydas A, Kaufer DI, Kerwin DR, Knopman DS, Kraft R, Kremers WK, Kukull WA, Litvan I, Lucente D, Lungu C, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley E, Mendez MF, Miller BL, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wang P, Wong B, Wszolek Z, Boxer AL, Boeve BF, Kramer JH, Rosen HJ; ARTFL/LEFFTDS consortium. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020 Jan;16(1):11-21. doi: 10.1016/j.jalz.2019.01.012.
- Van Deerlin VM, Wood EM, Moore P, Yuan W, Forman MS, Clark CM, Neumann M, Kwong LK, Trojanowski JQ, Lee VM, Grossman M. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch Neurol. 2007 Aug;64(8):1148-53. doi: 10.1001/archneur.64.8.1148.
- van Swieten JC, Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol. 2008 Oct;7(10):965-74. doi: 10.1016/S1474-4422(08)70194-7. Epub 2008 Sep 2.
- Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol. 2010 Feb;67(2):161-70. doi: 10.1001/archneurol.2009.328.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

